Galderma Group AG Stock: price and insider trades · Switzerland

Galderma Group AG, classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SIX SER. Over the twelve months to 18 October 2026, the company's managers filed 32 filings, from 4 insiders.

Purchases and sales both appear in the filings: 9 purchases (2 insiders, €25.5M) and 23 sales (4 insiders, €51.6M). The net balance comes to €26.1M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a sale of €8.4M, published on 31 July 2026, equal to 0.021% of the market capitalisation. On the buying side, the filings list 2 senior executives among the declarants.

Within a 30-day window, 5 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (28 April 2026) now reads 172 days. Publication is fast: at least half of the trades appear on SIX SER on the same day. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

For context, the typical company on the same exchange (median of 178 companies) published 9 filings over the same period, against 32 filings here. Looking back to 2024, when coverage begins, insiders filed 13 purchases and 56 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from SIX SER disclosures alone and does not predict where the share price will go.